/VETO.PA
VETO.PA Stock - Vetoquinol S.A.
Healthcare|Drug Manufacturers - Specialty & GenericPAR
$83.10-0.72%
$0.60 (-0.72%) • Dec 23
71
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.80
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.80
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $91.41
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for VETO.PA
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$82.27 – $83.93
TARGET (TP)$95.56
STOP LOSS$76.45
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.99
52W High$85.60
52W Low$63.60
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $539.20M | $529.27M | $539.78M | $521.27M | $427.47M |
| Gross Profit | $387.45M | $291.38M | $172.37M | $167.37M | $123.98M |
| Gross Margin | 71.9% | 55.1% | 31.9% | 32.1% | 29.0% |
| Operating Income | $77.32M | $74.26M | $74.00M | $86.28M | $37.09M |
| Net Income | $58.69M | $55.56M | $47.99M | $62.86M | $19.22M |
| Net Margin | 10.9% | 10.5% | 8.9% | 12.1% | 4.5% |
| EPS | $4.98 | $4.70 | $4.06 | $5.31 | $1.63 |
Company Overview
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, and dogs. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
VETO.PABeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$2.13
Q3 2025
EPS Surprise History
Q2 22
No data
Q4 22
No data
Q1 23
No data
Q4 23
No data
Q2 24
No data
Q4 24
No data
Q1 25
No data
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2026 | Sep 9, 2026 | — | — | — | — |
Q1 2026 | Mar 18, 2026 | — | — | — | — |
Q3 2025 | Sep 11, 2025 | — | $2.13 | — | — |
Q1 2025 | Mar 20, 2025 | — | $2.96 | — | — |
Q4 2024 | Oct 31, 2024 | — | $2.01 | — | — |
Q2 2024 | Apr 29, 2024 | — | $1.97 | — | — |
Q4 2023 | Oct 26, 2023 | — | $2.72 | — | — |
Q1 2023 | Mar 23, 2023 | — | $2.25 | — | — |
Q4 2022 | Oct 13, 2022 | — | $1.81 | — | — |
Q2 2022 | Apr 13, 2022 | — | $2.25 | — | — |
Q4 2021 | Oct 14, 2021 | — | $3.06 | — | — |
Q2 2021 | Apr 16, 2021 | — | $0.35 | — | — |
Q3 2020 | Jul 30, 2020 | — | $1.27 | — | — |
Q2 2020 | May 13, 2020 | — | $1.32 | — | — |
Q4 2019 | Oct 17, 2019 | — | $1.10 | — | — |
Q1 2019 | Mar 20, 2019 | — | $1.73 | — | — |
Q4 2018 | Oct 18, 2018 | — | $1.33 | — | — |
Q1 2018 | Mar 15, 2018 | — | $1.73 | — | — |
Q4 2017 | Oct 17, 2017 | — | $1.21 | — | — |
Q2 2017 | Apr 13, 2017 | — | $1.21 | — | — |
Latest News
Loading news...
Frequently Asked Questions about VETO.PA
What is VETO.PA's current stock price?
Vetoquinol S.A. (VETO.PA) is currently trading at $83.10 per share. The stock has moved -0.72% today.
What is the analyst price target for VETO.PA?
No analyst price targets are currently available for this stock.
What sector is Vetoquinol S.A. in?
Vetoquinol S.A. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the PAR exchange.
What is VETO.PA's market cap?
Vetoquinol S.A. has a market capitalization of $0.98 billion, making it a small-cap company.
Does VETO.PA pay dividends?
No, Vetoquinol S.A. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAB.PA
AB Science S.A.
$1.38
Mkt Cap: $0.1B
ALRPD.PA
Rapid Nutrition PLC
$0.00
Mkt Cap: $0.0B
BOI.PA
Boiron S.A.
$30.40
Mkt Cap: $0.5B
EQS.PA
Equasens S.A.
$43.25
Mkt Cap: $0.7B
GDS.PA
Ramsay Générale de Santé S.A.
$8.82
Mkt Cap: $1.0B
IVA.PA
Inventiva S.A.
$3.96
Mkt Cap: $0.6B
LBIRD.PA
Lumibird S.A.
$20.90
Mkt Cap: $0.5B
MEDCL.PA
MedinCell S.A.
$25.14
Mkt Cap: $0.8B
NANO.PA
Nanobiotix S.A.
$20.00
Mkt Cap: $1.0B
VLA.PA
Valneva SE
$3.69
Mkt Cap: $0.6B
Explore stocks similar to VETO.PA for comparison